Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1
Cancer Letters- Ireland
doi 10.1016/j.canlet.2018.10.037
Full Text
Abstract
Available in
Date
February 1, 2019
Authors
Publisher
Elsevier BV